交易 AbCellera Biologics Inc - ABCL 差价合约

交易条件

• 类型: 差价合约
• 点差: 0.05
• 长仓隔夜仓息调整: -0.02229%
• 短仓隔夜仓息调整: 0.00007%
• 隔夜调整仓息时间: 22:00 (UTC)
• 货币: USD
• 最低成交量: 10
• 保证金: 20.00%
• 证券交易所: United States of America
• 交易佣金: 0%
• 保证止损溢价: 1%

主要统计数据

• 前收盘价: 3.59
• 开仓: 3.78
• 1 年变化: 53.04%
• 日区间: 3.37 - 3.78

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, AI-powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. The company also develops next-generation transgenic mice that provide a source of fully-human antibodies for the discovery of therapeutic antibody candidates. It has a discovery partnership agreement with Eli Lilly and Company for the discovery of various targets. AbCellera Biologics Inc. was founded in 2012 and is headquartered in Vancouver, Canada.